ATE360017T1 - L-ascorbinsäure-2-o-maleinsäure-a- tocopheroldiester-1-propanol addukt und verfahren zu dessen herstellung - Google Patents
L-ascorbinsäure-2-o-maleinsäure-a- tocopheroldiester-1-propanol addukt und verfahren zu dessen herstellungInfo
- Publication number
- ATE360017T1 ATE360017T1 AT02733329T AT02733329T ATE360017T1 AT E360017 T1 ATE360017 T1 AT E360017T1 AT 02733329 T AT02733329 T AT 02733329T AT 02733329 T AT02733329 T AT 02733329T AT E360017 T1 ATE360017 T1 AT E360017T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- acid
- maleic acid
- ascorbic acid
- propanol adduct
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Otolaryngology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001171559 | 2001-06-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE360017T1 true ATE360017T1 (de) | 2007-05-15 |
Family
ID=19013310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02733329T ATE360017T1 (de) | 2001-06-06 | 2002-06-05 | L-ascorbinsäure-2-o-maleinsäure-a- tocopheroldiester-1-propanol addukt und verfahren zu dessen herstellung |
Country Status (8)
Country | Link |
---|---|
US (1) | US6828348B2 (de) |
EP (1) | EP1394161B1 (de) |
JP (1) | JP4179809B2 (de) |
KR (1) | KR100876371B1 (de) |
AT (1) | ATE360017T1 (de) |
DE (1) | DE60219620T2 (de) |
ES (1) | ES2281518T3 (de) |
WO (1) | WO2003006460A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007098467A2 (en) | 2006-02-21 | 2007-08-30 | Mary Kay, Inc. | Stable vitamin c compositions |
US10767259B2 (en) | 2013-07-19 | 2020-09-08 | Agilent Technologies, Inc. | Components with an atomic layer deposition coating and methods of producing the same |
US20150024152A1 (en) | 2013-07-19 | 2015-01-22 | Agilent Technologies, Inc. | Metal components with inert vapor phase coating on internal surfaces |
JP2019081726A (ja) * | 2017-10-30 | 2019-05-30 | 日光ケミカルズ株式会社 | エラスターゼ活性阻害剤 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4816901B1 (de) * | 1969-05-21 | 1973-05-25 | ||
JPS59219295A (ja) * | 1983-05-30 | 1984-12-10 | Senjiyu Seiyaku Kk | リン酸ジエステルまたはその塩およびそれらの製造法 |
JPS62205091A (ja) * | 1986-03-04 | 1987-09-09 | Senjiyu Seiyaku Kk | 新規なリン酸ジエステルならびにその塩、その製造法およびそれを含有する製剤 |
JPH0499772A (ja) | 1990-08-17 | 1992-03-31 | Kanebo Ltd | トコフェロール―5,6―0―イソプロピリデン―l―アスコルビン酸―2―ジカルボン酸ジエステル,及びその製造方法,並びにそれより成るビタミンc・ビタミンe補給剤 |
JPH04149113A (ja) | 1990-10-08 | 1992-05-22 | Kanebo Ltd | 美白化粧料 |
JP4346239B2 (ja) | 1997-12-24 | 2009-10-21 | 千寿製薬株式会社 | ビタミンe誘導体 |
KR20020025181A (ko) | 1999-07-08 | 2002-04-03 | 요시다 쇼지 | 말레산(또는 푸마르산) 디에스테르 화합물 |
-
2002
- 2002-06-05 EP EP02733329A patent/EP1394161B1/de not_active Expired - Lifetime
- 2002-06-05 AT AT02733329T patent/ATE360017T1/de not_active IP Right Cessation
- 2002-06-05 ES ES02733329T patent/ES2281518T3/es not_active Expired - Lifetime
- 2002-06-05 DE DE60219620T patent/DE60219620T2/de not_active Expired - Lifetime
- 2002-06-05 WO PCT/JP2002/005573 patent/WO2003006460A1/ja active IP Right Grant
- 2002-06-05 US US10/479,145 patent/US6828348B2/en not_active Expired - Lifetime
- 2002-06-05 JP JP2002164600A patent/JP4179809B2/ja not_active Expired - Lifetime
- 2002-06-05 KR KR1020037015786A patent/KR100876371B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
WO2003006460A1 (fr) | 2003-01-23 |
EP1394161A1 (de) | 2004-03-03 |
KR100876371B1 (ko) | 2008-12-29 |
EP1394161A9 (de) | 2004-07-07 |
DE60219620D1 (de) | 2007-05-31 |
ES2281518T3 (es) | 2007-10-01 |
US6828348B2 (en) | 2004-12-07 |
JP2003055374A (ja) | 2003-02-26 |
US20040171676A1 (en) | 2004-09-02 |
KR20040003046A (ko) | 2004-01-07 |
EP1394161B1 (de) | 2007-04-18 |
EP1394161A4 (de) | 2004-06-30 |
JP4179809B2 (ja) | 2008-11-12 |
DE60219620T2 (de) | 2008-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL300933I2 (nl) | Letermovir | |
PL1679386T3 (pl) | Blacha cienka ze stali magnetycznej o dużej wytrzymałości oraz przetworzona część z niej i sposób ich wytwarzania | |
DE60026354D1 (de) | Verfahren zur herstellung von methylcobalamin | |
ATE298322T1 (de) | Ss'-bis-(alpha, alpha'-disubstituierte-alpha''- essigsäure)-trithio-carbonate und derivate davon als initiatoren, kettentransfer-verbindung, kettenabbruch-verbindung für kontrollierte radikalische polymerisationen sowie verfahren zu deren herstellung | |
WO2006028958A3 (en) | Pyridyl inhibitors of hedgehog signalling | |
MX2007003031A (es) | Compuestos heteroarilo para uso como betamimeticos en el tratamiento de enfermedades de vias respiratorias. | |
MXPA02011458A (es) | Derivados de acilfenilurea, metodos para su produccion y uso de los mismos como farmacos. | |
HK1054967A1 (en) | Method of amplifying nucleic acid by using double-stranded nucleic acid as template | |
BR0017043A (pt) | Imidazo[1,3,5]triazinonas e sua aplicação | |
IL172015A (en) | Phosphonate grouping shaft compounds, method of preparation and use thereof for the preparation of drugs for the treatment of viral infection | |
WO2007065684A3 (en) | Bicyclic heteroyclic compounds as antiinflammatory or antiallergic agents | |
TW200509948A (en) | Prevention of urogenital infections | |
DE60310759D1 (de) | Pulver auf silber-basis, verfahren zu dessen herstellung, und härtbare siloxanzusammensetzung | |
CA2449480A1 (en) | Process for producing methylcobalamin | |
ATE506346T1 (de) | Verfahren zur herstellung von (z)-1-phenyl-1-(n,n-diethylaminocarbonyl)idomet ylcyclopropan | |
ATE360017T1 (de) | L-ascorbinsäure-2-o-maleinsäure-a- tocopheroldiester-1-propanol addukt und verfahren zu dessen herstellung | |
WO2004033423A3 (en) | Anticancer compounds | |
NL1027790A1 (nl) | Werkwijze voor vervaardigen van een fosfaat van de lanthaniden en daaruit vervaardigd fosfaat. | |
ATE464382T1 (de) | Mutageneseverfahren | |
DE60201984D1 (de) | Werkzeugstahl von hoher zähigkeit, verfahren zum herstellen von teilen aus diesem stahl und so hergestellte teile | |
WO2005047278A3 (de) | Substituierte dihydrochinazoline ii | |
BRPI0415529A (pt) | derivados de bengamida, processos para produção dos mesmos e uso dos mesmos para tratamento de doenças cancerosas | |
ATE466847T1 (de) | Verfahren zur herstellung von 14-beta- hydroxybaccatin-iii-1,14-carbonat | |
ATE537160T1 (de) | Verfahren zur herstellung von 14beta- hydroxybaccatin-iii-1,14-carbonat | |
MXPA04000623A (es) | Derivados de tetrahidropiridazina y su uso como pesticidas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |